Editas Medicine (EDIT)
(Real Time Quote from BATS)
$10.75 USD
+0.14 (1.32%)
Updated Nov 30, 2023 09:58 AM ET
3-Hold of 5 3
F Value C Growth A Momentum D VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 18% (45 out of 251)Zacks Sector Rank
Top 6% (1 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.11 | 1.35 | 9.99 |
Current Quarter Estimate | -0.61 | 7.43 | 58.00 |
Year Ago Quarter Estimate | -0.88 | 0.12 | 50.35 |
Next Quarter Estimate | -0.66 | 7.81 | 59.00 |
Next Year Estimate | -2.54 | 37.76 | 250.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 24.61 | 15.30 | 14.24 |
Next Year | -4.96 | 11.40 | 11.11 |
Last 5 Years | -379.20 | 10.50 | 9.00 |
Next 5 Years | 13.80 | 21.40 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -2.18 |
Price/Book (MRQ) | 2.40 | 1.61 |
Price/Cash Flow (MRFY) | NA | 11.79 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -792.70% | -198.80% |
Return on Equity (TTM) | -54.25% | -60.65% |
Debt to Equity (MRQ) | 0.00 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.